Antonio Vitiello (A Vitiello)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 54

Top Topics

Systematic Review

Antimicrobial Resistance

Respiratory Syndrome Coronavirus

Angiotensin Converting Enzyme

Top Venues

Inflammopharmacology

Naunyn-Schmiedeberg's archives of pharmacology

The AAPS journal

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Vitiello, Michela Sabbatucci, Andrea Zovi, Antonio Salzano, Annarita Ponzo, Mariarosaria Boccellino
Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection. Journal of clinical medicine 13 (5) (2024)
Antonio Vitiello, Giovanni Rezza, Andrea Silenzi, Antonio Salzano, Mosè Alise, Maria Rosaria Boccellino, Annarita Ponzo, Andrea Zovi, Michela Sabbatucci
Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens. Pharmaceutical research 41 (8) (2024)
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, Antonio Salzano, Andrea Zovi
A Short Update on the Use of Monoclonal Antibodies in COVID-19. The AAPS journal 26 (2) (2024)
Antonio Vitiello, Giovanni Rezza, Andrea Silenzi, Antonio Salzano, Mosè Alise, Maria Rosaria Boccellino, Annarita Ponzo, Andrea Zovi, Michela Sabbatucci
Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens. Pharmaceutical research 41 (8) (2024)
Antonio Vitiello, Michela Sabbatucci, Antonio Salzano, Andrea Zovi
The importance of antibiotic treatment duration in antimicrobial resistance. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology (2024)
Antonio Vitiello, Michela Sabbatucci, Antonio Salzano, Andrea Zovi
The importance of antibiotic treatment duration in antimicrobial resistance. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 43 (8) (2024)
Antonio Vitiello, Michela Sabbatucci, Antonio Salzano, Andrea Zovi
The importance of antibiotic treatment duration in antimicrobial resistance. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 43 (8) (2024)
Antonio Vitiello, Giovanni Rezza, Andrea Silenzi, Antonio Salzano, Mosè Alise, Maria Rosaria Boccellino, Annarita Ponzo, Andrea Zovi, Michela Sabbatucci
Therapeutic Strategies to Combat Increasing Rates of Multidrug Resistant Pathogens. Pharmaceutical research (2024)
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, Antonio Salzano, Andrea Zovi
A Short Update on the Use of Monoclonal Antibodies in COVID-19. The AAPS journal 26 (2) (2024)
Antonio Vitiello, Michela Sabbatucci, Andrea Zovi, Antonio Salzano, Annarita Ponzo, Mariarosaria Boccellino
Advances in Therapeutic Strategies for the Management of Clostridioides difficile Infection. Journal of clinical medicine 13 (5) (2024)
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, Antonio Salzano, Andrea Zovi
A Short Update on the Use of Monoclonal Antibodies in COVID-19. The AAPS journal 26 (2) (2024)
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, Andrea Zovi, Francesco Miele, Annarita Ponzo, Roberto Langella, Mariarosaria Boccellino
The Impact of Antimicrobial Resistance in Cystic Fibrosis. Journal of clinical medicine 13 (6) (2024)
Antonio Vitiello, Michela Sabbatucci, Annarita Ponzo, Antonio Salzano, Andrea Zovi
A Short Update on the Use of Monoclonal Antibodies in COVID-19. The AAPS journal 26 (2) (2024)
Antonio Vitiello, Francesco Blasi, Michela Sabbatucci, Andrea Zovi, Francesco Miele, Annarita Ponzo, Roberto Langella, Mariarosaria Boccellino
The Impact of Antimicrobial Resistance in Cystic Fibrosis. Journal of clinical medicine 13 (6) (2024)
Antonio Vitiello, Francesco Ferrara, Andrea Zovi
The direct correlation between microbiota and SARS-CoV-2 infectious disease. Inflammopharmacology (2023)
Antonio Vitiello, Francesco Ferrara, Andrea Zovi
The direct correlation between microbiota and SARS-CoV-2 infectious disease. Inflammopharmacology (2023)
Michela Sabbatucci, Antonio Vitiello, Salvatore Clemente, Andrea Zovi, Mariarosaria Boccellino, Francesco Ferrara, Carla Cimmino, Roberto Langella, Annarita Ponzo, Paola Stefanelli, Giovanni Rezza
Omicron variant evolution on vaccines and monoclonal antibodies. Inflammopharmacology (2023)
Francesco Ferrara, Andrea Zovi, Marta Masi, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino, Annarita Ponzo, Carla Cimmino, Emilio Comberiati, Andrea Zovi, Salvatore Clemente, Michela Sabbatucci
Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines 11 (4) (2023)
Francesco Ferrara, Andrea Zovi, Marta Masi, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
Long COVID could become a widespread post-pandemic disease? A debate on the organs most affected. Naunyn-Schmiedeberg's archives of pharmacology (2023)
Raffaella Di Napoli, Nunzia Balzano, Annamaria Mascolo, Carla Cimmino, Antonio Vitiello, Andrea Zovi, Annalisa Capuano, Mariarosaria Boccellino
What Is the Role of Nutraceutical Products in Cancer Patients? A Systematic Review of Randomized Clinical Trials. Nutrients 15 (14) (2023)
Andrea Zovi, Francesco Ferrara, Roberto Langella, Fabiola Cavallaro, Antonio Vitiello
Sex affects immune response capacity against COVID-19 infection. Reviews in medical virology (2023)
Samina Sana, Elisa Fabbro, Andrea Zovi, Antonio Vitiello, Toluwani Ola-Ajayi, Ziad Zahoui, Bukola Oladunni Salami, Michela Sabbatucci
Scoping Review on Barriers and Challenges to Pediatric Immunization Uptake among Migrants: Health Inequalities in Italy, 2003 to Mid-2023. Vaccines 11 (9) (2023)
Antonio Vitiello, Francesco Ferrara, Mariarosaria Boccellino, Annarita Ponzo, Carla Cimmino, Emilio Comberiati, Andrea Zovi, Salvatore Clemente, Michela Sabbatucci
Antifungal Drug Resistance: An Emergent Health Threat. Biomedicines 11 (4) (2023)
Francesco Ferrara, Andrea Zovi, Ugo Trama, Antonio Vitiello
Nirmatrelvir-remdesivir association for non-hospitalized adults with COVID-19, point of view. Inflammopharmacology 30 (5) (2022)
Antonio Vitiello, Raffaele La Porta, Ugo Trama, Valentina Troiano, Francesco Ferrara
Pleiotropic effects of AT-1 receptor antagonists in hypoxia induced by cardiac ischaemia. Inflammopharmacology 30 (4) (2022)
Francesco Ferrara, Carolina Mancaniello, Alessia Varriale, Sarah Sorrentino, Andrea Zovi, Eduardo Nava, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
COVID-19 mRNA Vaccines: A Retrospective Observational Pharmacovigilance Study. Clinical drug investigation 42 (12) (2022)
Antonio Vitiello, Francesco Ferrara
Pharmacotherapy Based on ACE2 Targeting and COVID-19 Infection. International journal of molecular sciences 23 (12) (2022)
Antonio Vitiello, Francesco Ferrara, Amogh M Auti, Marina Di Domenico, Mariarosaria Boccellino
Advances in the Omicron variant development. Journal of internal medicine 292 (1) (2022)
Antonio Vitiello, Andrea Zovi, Ugo Trama, Francesco Ferrara
Overview of pharmacotherapy targeting COVID-19 disease based on ACE-2: current challenges and future directions. Herz (2022)
Antonio Vitiello, V Troiano, R La Porta
Statins in Alzheimer's disease (AD). European journal of clinical pharmacology 78 (7) (2022)
Andrea Zovi, Francesco Ferrara, Sarah Sorrentino, Roberto Langella, Ugo Trama, Mariarosaria Boccellino, Antonio Vitiello
What Do We Know About the Smallpox Virus? A Journey Between Clinic and Therapy. Pharmaceutical research (2022)
Antonio Vitiello, Francesco Ferrara, Raffaele La Porta
Remdesivir and COVID-19 infection, therapeutic benefits or unnecessary risks? Irish journal of medical science 190 (4) (2021)
Antonio Vitiello, Francesco Ferrara
Brief review of the mRNA vaccines COVID-19. Inflammopharmacology 29 (3) (2021)
Antonio Vitiello, Valentina Troiano, Raffaele La Porta
What will be the role of molnupiravir in the treatment of COVID-19 infection? Drugs & therapy perspectives : for rational drug selection and use (2021)
Francesco Ferrara, Antonio Vitiello
The advantages of drug treatment with statins in patients with SARS-CoV-2 infection. Wiener klinische Wochenschrift 133 (17-18) (2021)
Antonio Vitiello, Francesco Ferrara
A short focus, azithromycin in the treatment of respiratory viral infection COVID-19: efficacy or inefficacy? Immunologic research (2021)
Antonio Vitiello, Raffaele La Porta, Vilma D'Aiuto, Francesco Ferrara
The risks of liver injury in COVID-19 patients and pharmacological management to reduce or prevent the damage induced. Egyptian liver journal 11 (1) (2021)
Francesco Ferrara, Antonio Vitiello
Efficacy of synthetic glucocorticoids in COVID-19 endothelites. Naunyn-Schmiedeberg's archives of pharmacology 394 (5) (2021)
Antonio Vitiello
Sars-Cov-2 and risk of antiviral drug resistance. Irish journal of medical science (2021)
Antonio Vitiello, Francesco Ferrara
Perspectives of association Baricitinib/Remdesivir for adults with Covid-19 infection. Molecular biology reports (2021)
Antonio Vitiello, F Ferrara, V Troiano, R La Porta
COVID-19 vaccines and decreased transmission of SARS-CoV-2. Inflammopharmacology 29 (5) (2021)
Francesco Ferrara, Antonio Vitiello
The renin-angiotensin system and specifically angiotensin-converting enzyme 2 as a potential therapeutic target in SARS-CoV-2 infections. Naunyn-Schmiedeberg's archives of pharmacology 394 (7) (2021)
Francesco Ferrara, Laura Pianesi, Antonio Vitiello
COVID-19 global pandemic: vaccines and new monoclonal antibodies, aspects to be clarified. Immunologic research 69 (2) (2021)
Antonio Vitiello, Francesco Ferrara
Plausible Positive Effects of Statins in COVID-19 Patient. Cardiovascular toxicology 21 (10) (2021)
Antonio Vitiello, Raffaele La Porta, Valentina Troiano, Francesco Ferrara
COVID-19 vaccination in pregnancy. Drugs & therapy perspectives : for rational drug selection and use (2021)
Antonio Vitiello, Francesco Ferrara
Low Molecular Weight Heparin, Anti-inflammatory/Immunoregulatory and Antiviral Effects, a Short Update. Cardiovascular drugs and therapy (2021)
Francesco Ferrara, Antonio Vitiello
Scientific Hypothesis for Treatment of COVID-19's Lung Lesions by Adjusting ACE/ACE2 Imbalance. Cardiovascular toxicology 21 (6) (2021)
Antonio Vitiello, Francesco Ferrara
Risk of drug-induced cardiac arrhythmia during COVID-19 therapeutic treatment. The Egyptian heart journal : (EHJ) : official bulletin of the Egyptian Society of Cardiology 73 (1) (2021)
Antonio Vitiello, Francesco Ferrara
Association and pharmacological synergism of the triple drug therapy baricitinib/remdesivir/rhACE2 for the management of COVID-19 infection. Naunyn-Schmiedeberg's archives of pharmacology (2021)
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
Sacubitril, valsartan and SARS-CoV-2. BMJ evidence-based medicine (2020)
Antonio Vitiello, Raffaele La Porta, Francesco Ferrara
Correlation between the use of statins and COVID-19: what do we know? BMJ evidence-based medicine (2020)
Antonio Vitiello, Francesco Ferrara
Remdesivir versus ritonavir/lopinavir in COVID-19 patients. Irish journal of medical science 190 (3) (2020)
Francesco Ferrara, Raffaele La Porta, Vilma D'Aiuto, Antonio Vitiello
Remdesivir and COVID-19. Irish journal of medical science 190 (3) (2020)